Convulsions, hypertension crisis and acute renal failure in postpartum: Role of bromocriptine?

Nephron

Volumn 72, Issue 4, 1996, Pages 732-733

  Makdassi, R ^a   Cagny, B De ^a   Lobjoie, E ^a   Andrejak M ^a   Fournier, A ^a  

^a Service de Néphrologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ACUTE KIDNEY FAILURE; ADULT; CASE REPORT; CONVULSION; FEMALE; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; PUERPERIUM;

ADULT; BROMOCRIPTINE; DOPAMINE AGONISTS; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, ACUTE; MALE; POSTPARTUM PERIOD; SEIZURES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029872055     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188982     Document Type: Article

References (16)

1. Varga I., Lutterbeck PM., Pryor JS, Werner R., Erb H: Suppression of puerperal lactation with an ergot alkaloid: A double-blind studv., Br Med J 1972:vol ii:743-744.
2. Montastruc JL, Montastruc P: Alpha-adrenolytic properties of bromocriptine in dogs., Arch Int Pharmacodyn Ther 1982:260:83-90.
3. Lewis MJ: Bromocriptine in hypertension., Br.l HospMed 1978;20:661-662.
4. Wass JAH, Tliomcr MO, Besser GM: Digital vasospasm with bromocriptine., Lancet 1976;Vol i: 1135.
5. Iffy I., Tenhove W., Frisoli G: Acute myocardial infarction in the puerperium in patients receiving bromocriptine., Am J Obstet Gynecol 1986:155:371-372.
6. Katz M., Kroll D., Pak I, Osimons A., Hirsch M: Puerperal hypertension stroke and seizures after suppression of lactation with bromocriptine., Obstet Gynecol 1985:66:822-824.
7. Bakht FR., Kirshon B., Baker T., Cotton DB: Post-partum cardiovascular complications after bromocriptine and cocaine use., Am J Obstet Gynecol 1990:162:1065-1066.
8. Ruch A, Duhring JL: Post-partum myocardial infarction in a patient receiving bromocriptine., Obstet Gynecol 1989;74:448-451.
9. Eickman FM: Recurrent myocardial infarction in a post-partum patient receiving bromocriptine., Clin Cardiol 1992:15:781-783.
10. Larrazet F, Spaulding C., Lobreau HJ., Weber S., Guerin F: Possible bromocriptine-induced myocardial infarction., Ann Intern Med 1993: 118:199-200.
11. Gittelman DK: Bromocriptine associated with post-partum hypertension, seizures and pituitary hemorrhage., Gen Hosp Psvchiatrv 1991: 13:278-280.
12. FDA Drug Bulletin: Post-partum hypertension seizures, strokes reported with bromocriptine., FDA Drug Bull 1994:14:3-4.
13. Sandoz Pharmaceuticals (Parlodel* package insert): Physician desk reference., 44th edition Medical Economics OradelI., 1990., pp 1947-1948.
14. Watson D., Bhatia RK., Norman GS., Brindley BA., Sokol RJ: Bromocriptine mesylate for lactation suppression: A risk for post-partum hypertension., Obstet Gynecol 1989:74:573-576.
15. Christ W, Lchnert T., Ulbrich B: Specific toxicologic aspects of the quinoloncs., Rev Infect Dis 1988:10 (suppl):S141-S146.
16. Lubarsky SL, Barton JR., Friedman SA., Nas-reddine S., Ramadan M., Sibai BM: Late postpartum eclampsia revisited., Obstet Gvnecol 1994:83:502-505